APCO WORLDWIDE LLC

Lobbying for HIKMA PHARMACEUTICALS USA INC. · Pharmaceutical manufacturer

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $30,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Health Issues

Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues

Trade (domestic/foreign)

Trade policies impacting domestic generic pharmaceutical manufacturing

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.